Latest Transformation News

Deterra Royalties announces the resignation of CEO Julian Andrews by year-end, with Non-executive Director Jason Neal stepping in as interim CEO amid a search for a permanent replacement.

Genesis Energy reported a robust start to FY26, boosted by strong hydro generation and strategic digital investments, setting a positive tone for the year ahead.

Torque Metals reports breakthrough drilling results at its Paris Gold Project, extending high-grade gold mineralisation beyond existing resources and maintaining strong financial footing for ongoing exploration.

Mont Royal Resources has finalized its merger with Commerce Resources, creating a dual-listed critical metals company focused on advancing one of North America’s largest rare earth deposits in Québec. Backed by a fresh A$10 million capital raise and a seasoned leadership team, Mont Royal is poised to become a key player in the global rare earths market.

Great Northern Minerals has secured full ownership of the Catalyst Ridge Project in California’s Mountain Pass District, initiating exploration backed by a $2.6 million capital raise and strategic US appointments.

Sigma Healthcare’s 2025 AGM reveals a robust year of transformation post-merger with Chemist Warehouse, highlighted by upgraded synergy targets and impressive financial gains.

Sigma Healthcare’s transformative merger with Chemist Warehouse has propelled the company into Australia’s top 20 ASX firms, with FY25 results exceeding expectations and synergy targets nearly doubling.

Maas Group Holdings delivered a record $219.4 million Underlying EBITDA in FY25, driven by strategic acquisitions and disciplined capital recycling. The company projects further growth with FY26 EBITDA guidance between $240 million and $270 million amid stable market conditions and expanding renewable energy projects.

MedAdvisor Solutions reported a steep 52.8% revenue decline in Q1 FY26, impacted by US regulatory pressures and vaccine program delays, while embarking on a strategic transformation to restore growth.

MedAdvisor reports a sharp 53% drop in 1Q FY26 revenue driven by U.S. regulatory and sector challenges, while advancing a major platform transformation and selling its ANZ business to emerge debt-free.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

ACDC Metals reports compelling mineralogy results from its Goschen Central project, highlighting elevated rare earth element grades that reinforce its economic potential. The announcement coincides with strategic momentum from the Australia-US Critical Minerals Framework, positioning the project as a key player in global supply chains.